Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327

Journal of Applied Toxicology

Volumn 21, Issue 1, 2001, Pages 25-31

  Sciuto, A M ^a   Moran, T S ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Locomotor activity; Mice; Nimodipine; Phosphorothioate; Radiation protective agents; WR 151327

Indexed keywords

NIMODIPINE; PHOSPHOROTHIOIC ACID; PHOSPHOROTHIOIC ACID S 3 (3 METHYLAMINOPROPYLAMINO)PROPYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR CALCIUM; GAMMA IRRADIATION; INFECTION RESISTANCE; IONIZING RADIATION; LOCOMOTION; MOUSE; NEUTRON RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; LETHAL DOSE 50; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NIMODIPINE; ORGANOTHIOPHOSPHORUS COMPOUNDS; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; SURVIVAL RATE; TIME FACTORS;

ANIMALIA;

EID: 0035138909     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.728     Document Type: Article

References (42)

1. Calcium antagonism tissue protection
2. Reductions in calcium uptake induced in rat brain synaptosomes by ionizing radiation
3. Calcium antagonists protect mice against the lethal effects of ionizing radiation
4. Radioprotective effects of calcium antagonists used alone or with other types of radioprotectors
5. Calcium antagonist verapamil enhances the radioprotective efficacy of WR-2721 in whole-body irradiated mice
6. Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through anti-radical mechanism
7. Beta blockers, calcium channel blockers and the sulfhydryl-ACE inhibitors demonstrate protection against free-radical mediated injury of cardiovascular cells and membranes
8. Pharmacology of nimodipine. A review
9. Short-term effects of calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia
10. Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin
11. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327
12. Protection of WR-151327 against late-effect damage from fission-spectrum neutrons
13. Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons
14. Radioprotection by WR-151327 against late normal tissue damage in mouse hind legs from gamma ray radiation
15. Preclinical evaluation of WR-151327: An orally active chemoprotector
16. 60Co gamma rays
17. Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector
18. Pharmacologic approaches to protection against radiation-induced lethality and other damage
19. Advances in radioprotection through the use of combined agent regimens
20. Reduction of Pseudomonas aeruginosa and coliform bacteria in mouse drinking water following treatment with hydrochloric acid or chlorine
21. Behavioral effects of vehicles: DMSO, ethanol, Tween-20, Tween-80, and Emulphor-620
22. A protocol for the determination of absorbed dose from high-energy photon and electron beams
23. Haematopoieic radioprotection by Cremophor EL: A polyethoxylated castor oil
24. Dose and time relationships of the radioprotector WR-2721 on locomotor activity in mice
25. Behavioral toxicity of selected radioprotectors
26. Synthetic trehalose dicorynomycolate (S-TDCM): Behavioral effects and radioprotection
27. Long-term effects of radioprotector WR-2721 on locomotor activity and body weight of mice following exposure to ionizing radiation
28. Motor activity and screening for neurotoxicity
29. Differences between calcium channel inhibitors in their effects on phencyclidine-induced behavioral stimulation in mice
30. Final report on phase I trial of WR-2721 before protracted radiation therapy
31. Hypotensive mechanisms of amifostine
32. Continuous infusion of nimodipine during coronary surgery: Haemodynamic and pharmokinetic study
33. Effect of nimodipine on brightness discrimination learning test in Wistar Kyoto and spontaneously hypertensive rats
34. Pharmacodynamics of the hypotensive effects of levodopa in parkinsonian patients
35. Calcium antagonist radioprotectors do not reduce radiotherapeutic efficacy in three human tumor xenografts
36. Calcium antagonists as radiation modifiers: Site specificity in relation to tumor response
37. New uses for calcium channel blockers: Therapeutic implications
38. Antioxidant effect of calcium antagonists on microsomal membranes isolated from different brain areas
39. Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system
40. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation